These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 6382207)
1. [Non-steroid inflammatory drugs in the prevention of myocardial infarction]. Basista M; Kostka-Trabka E Pol Tyg Lek; 1983 Dec 19-26; 38(51-52):1645-8. PubMed ID: 6382207 [No Abstract] [Full Text] [Related]
2. [Blood platelets and myocardial infarction]. Musiał J; Dworski R; Szczeklik A Pol Tyg Lek; 1984 Dec; 39(50):1665-8. PubMed ID: 6396594 [No Abstract] [Full Text] [Related]
3. [Pro and con: Aggregation inhibitors in the prophylaxis of myocardial infarct. Arguments against aggregation inhibitors]. Reuter HD Internist (Berl); 1980 Jul; 21(7):390-2. PubMed ID: 7007277 [No Abstract] [Full Text] [Related]
5. [Pro and con: Aggregation inhibitors in the prophylaxis of myocardial infarct. Arguments in favor of aggregation inhibitors]. Walter E; Weber E Internist (Berl); 1980 Jul; 21(7):387-9. PubMed ID: 7007276 [No Abstract] [Full Text] [Related]
6. The enigma of aspirin. Parkin JD Aust N Z J Med; 1987 Apr; 17(2):192-4. PubMed ID: 3304245 [No Abstract] [Full Text] [Related]
7. [Theories on the mechanism of action of non-steroid anti-inflammatory drugs]. Stochla K Pol Tyg Lek; 1980 Dec; 35(48):1875-8. PubMed ID: 7010329 [No Abstract] [Full Text] [Related]
8. Selective inhibition of thromboxane-related platelet function by low-dose aspirin in patients after myocardial infarction. De Caterina R; Giannessi D; Bernini W; Gazzetti P; Michelassi C; L'Abbate A; Donato L; Patrignani P; Filabozzi P; Patrono C Am J Cardiol; 1985 Feb; 55(5):589-90. PubMed ID: 3969908 [No Abstract] [Full Text] [Related]
9. [Summary: Secondary prophylaxis following myocardial re-infarct. Anticoagulants or thrombocyte function inhibitors?]. Breddin K; Loeliger EA Internist (Berl); 1980 Jul; 21(7):399. PubMed ID: 7007281 [No Abstract] [Full Text] [Related]
13. [Function of prostaglandins in platelet aggregation]. Sun QW Sheng Li Ke Xue Jin Zhan; 1980 Feb; 11(2):137-42. PubMed ID: 7001620 [No Abstract] [Full Text] [Related]
14. Aspirin and its rivals. As your options increase, your choices get harder. Harv Mens Health Watch; 2002 Dec; 7(5):1-5. PubMed ID: 12499131 [No Abstract] [Full Text] [Related]
15. [Prevention of reinfarction with 100 mg or 30 mg ASS daily?]. Förster W Z Kardiol; 1995 May; 84(5):335-43. PubMed ID: 7625094 [TBL] [Abstract][Full Text] [Related]
16. Can aspirin prevent myocardial infarction? Med Lett Drugs Ther; 1975 Mar; 17(6):25-6. PubMed ID: 1092992 [No Abstract] [Full Text] [Related]
17. [Results of prevention of second myocardial infarct with syncumar or aspirin]. Kraska T; Malanowicz W; Skarzyńska M; Tymińska K Kardiol Pol; 1981; 24(9):593-7. PubMed ID: 7029110 [No Abstract] [Full Text] [Related]
18. Is there an optimal dose and formulation of aspirin to prevent arterial thrombo-embolism in man? Bochner F; Lloyd J Clin Sci (Lond); 1986 Dec; 71(6):625-31. PubMed ID: 3098493 [No Abstract] [Full Text] [Related]
19. [Secondary prevention of ischemic cardiopathy with anti-platelet aggregates in the post-infarct patient. Review]. Verdecchia P G Ital Cardiol; 1982; 12(8):598-603. PubMed ID: 6762978 [No Abstract] [Full Text] [Related]